99 related articles for article (PubMed ID: 20070285)
1. Estradiol limits viral replication following intravaginal immunization leading to diminished mucosal IgG response and non-sterile protection against genital herpes challenge.
Gillgrass A; Chege D; Bhavanam S; Kaushic C
Am J Reprod Immunol; 2010 Apr; 63(4):299-309. PubMed ID: 20070285
[TBL] [Abstract][Full Text] [Related]
2. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
Gillgrass AE; Tang VA; Towarnicki KM; Rosenthal KL; Kaushic C
J Virol; 2005 Mar; 79(5):3117-26. PubMed ID: 15709031
[TBL] [Abstract][Full Text] [Related]
3. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2.
Kwant A; Rosenthal KL
Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061
[TBL] [Abstract][Full Text] [Related]
4. Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone.
Bhavanam S; Snider DP; Kaushic C
Vaccine; 2008 Nov; 26(48):6165-72. PubMed ID: 18804503
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.
Milligan GN; Dudley-McClain KL; Chu CF; Young CG
Virology; 2004 Jan; 318(2):507-15. PubMed ID: 14972519
[TBL] [Abstract][Full Text] [Related]
6. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
7. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
Gallichan WS; Rosenthal KL
Virology; 1996 Oct; 224(2):487-97. PubMed ID: 8874509
[TBL] [Abstract][Full Text] [Related]
8. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
9. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
Tengvall S; Harandi AM
J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
[TBL] [Abstract][Full Text] [Related]
10. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
11. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
12. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15.
Gill N; Ashkar AA
Eur J Immunol; 2007 Sep; 37(9):2529-38. PubMed ID: 17668897
[TBL] [Abstract][Full Text] [Related]
13. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
[TBL] [Abstract][Full Text] [Related]
14. Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge.
Sajic D; Ashkar AA; Patrick AJ; McCluskie MJ; Davis HL; Levine KL; Holl R; Rosenthal KL
J Med Virol; 2003 Dec; 71(4):561-8. PubMed ID: 14556270
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice.
Del Campo J; Lindqvist M; Cuello M; Bäckström M; Cabrerra O; Persson J; Perez O; Harandi AM
Vaccine; 2010 Feb; 28(5):1193-200. PubMed ID: 19945418
[TBL] [Abstract][Full Text] [Related]
16. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
Milligan GN; Bernstein DI; Bourne N
J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
[TBL] [Abstract][Full Text] [Related]
17. Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge.
Evans IA; Jones CA
J Infect Dis; 2002 Jun; 185(11):1550-60. PubMed ID: 12023760
[TBL] [Abstract][Full Text] [Related]
18. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge.
Morrison LA; Da Costa XJ; Knipe DM
Virology; 1998 Mar; 243(1):178-87. PubMed ID: 9527927
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes.
Sherwood JK; Zeitlin L; Whaley KJ; Cone RA; Saltzman M
Nat Biotechnol; 1996 Apr; 14(4):468-71. PubMed ID: 9630921
[TBL] [Abstract][Full Text] [Related]
20. Decreased vaginal disease in J-chain-deficient mice following herpes simplex type 2 genital infection.
Hendrickson BA; Guo J; Brown I; Dennis K; Marcellino D; Hetzel J; Herold BC
Virology; 2000 May; 271(1):155-62. PubMed ID: 10814580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
